Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > New base $2

<< Previous

Bullboard Posts

Next >>

Comment by Metalsguy1on Jan 06, 2022 1:21pm

197 Views

Post# 34289753

RE:New base $2

Good points MS. I am happy to see a reasonable rise to genius over 2. At the same time, O am wondering whether management is actually going to take advantage of it and get news out that will keep it moving or...once again shoot themselves in the foot. I think the latter is less likely since they just handed out DSUs like Christmas candy at an orphanage.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland